Recombinant GH replacement in hypopituitary adults improves endothelial cell function and reduces calculated absolute and relative coronary risk - Abdu,T.A.; Elhadd,T.A.; Buch,H.; Barton,D.; Neary,R.; Clayton,R.N. (Clin Endocrinol (Oxf), 2004)